Tenders Are Invited For Pharmaceutical Products – Medicinal Product Containing The Active Substance Faricimab

Pharmaceutical Products – Medicinal Product Containing The Active Substance Faricimab. The Subject Of The Performance Of The Public Contract Is The Continuous Supply Of A Medicinal Product Containing The Active Ingredient Faricimab (Atc S01la09) For The Treatment Of Patients In Approved Indications According To The Spc Valid On The Date Of Submission Of Tenders, To The Extent According To The Needs Of The Contracting Authority. The Aim Of The Contracting Authority Is To Ensure For Its Activity The Continuous Supply Of Medicinal Products For The Treatment Of Patients For A Period Of 1 Year From The Entry Into Force Of The Framework Purchase Agreement.